Endovascular Aneurysm Repair Market size is forecast to reach $2.8 billion by 2025, growing at a CAGR of 6.8% during the forecast period 2020-2025. Endovascular aneurysm repair (EVAR) is a minimally invasive technique of endovascular surgery used to treat pathology of the aorta, most commonly an abdominal aortic aneurysm. When used to treat thoracic aortic disease, the procedure is then specifically termed TEVAR for “thoracic endovascular aortic aneurysm repair.” Thoracoabdominal aortic aneurysm (TAAA) is a related aortic disorder of elderly male smokers, many patients have serious cardiac and pulmonary co-morbidities. One of the recent form of treatments is endovascular stent grafting, which uses an endovascular stent graft to reinforce the wall of the aorta (known as aortic stent) and helps to keep the damaged area from rupturing. EVAR gives significant benefits over Open Aortic Surgery (OAS). Technological advancements in EVAR surgery, benefits over open surgery and increase in R&D activities and investments by key companies for further efficiency and improvement of EVAR are major factors that are driving the market growth in recent years. In addition, major developments by key market players like Medtronic and Endologix are other factors driving the growth of the market.
Request for Sample of the Report @ https://www.industryarc.com/pdfdownload.php?id=501984
Report Price: $ 4500 (Single User License)
Product Type – Segment Analysis
Percutaneous EVAR held the largest share in the product segment of Endovascular Aneurysm Repair Market in 2019 and is estimated to grow at a CAGR of 7.2% during the forecast period 2020-2025. Factors that contribute to the growth of this segment are the potential advantages of EVAR over traditional open repair include reduced time under general anesthesia, elimination of the pain and trauma associated with major abdominal surgery, reduced length of stay in the hospital and intensive care unit (ICU), and reduced blood loss. In recent years, various companies like Medtronic Plc have taken advantage of this, and innovated thoracic stent graft system, which is a low-profile device for minimally invasive repair of lesions of the descending thoracic aorta. Aortic Stent and TAA graft held the second largest share in 2019, owing to advantages like reduced recovery time and availability of better technologies for easier surgeries. Percutaneous EVAR is set to be the fastest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025, owing to major investments in technology and innovation for related products by key market players like Endologix.
Indication – Segment Analysis
Thoracic Aortic Aneurysm (TAA) segment holds the major share in the application segment of Endovascular Aneurysm Repair Market in 2019, owing to increasing demand for technologically advanced methods of thoracic aneurysm treatment around the world and the need for attention improve outcomes of TA treatments. Thoracic Aortic Aneurysm is forecast to continue growing at the fastest rate with the highest CAGR during the forecast period 2020-2025, owing to increased demand for avoiding risk factors in surgeries, faster recovery, and more investments by key market players.
Geography – Segment Analysis
North America dominates the geography segment of Endovascular Aneurysm Repair Market with a share of more than 43.7% in 2019, followed by Europe. Growing prevalence of aortic disorders like abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA), increasing healthcare affordability of the masses alongwith healthcare awareness growth and presence of key market players in the region have helped in the growth of Endovascular Aneurysm Repair Market infrastructure in this region. In autopsy studies, the frequency rate of AAA ranged from 0.5% to 3.2%. In a large US Veterans Affairs screening study, the prevalence was 1.4%. The likelihood of development ranges from 3 to 117 cases per 100,000 person-years. On the other hand, the estimated incidence of thoracic aortic aneurysms is 6 cases per 100,000 person-years. In addition, the overall prevalence of AAs has increased significantly in the past 30 years. A large number of treatments following up fuels the market growth by a large scale. Europe held the second place in the geography segment share of the market, owing to increasing health awareness among the masses, increasing cases of mortality by aortic aneurysm and technological improvements of treatment processes.
However, Asia-Pacific is estimated to grow at a higher CAGR during the forecast period 2020-2025. This is owing to growth of endovascular aneurysm repair in developing countries like China and India, entry of new players in the region and increasing demand for EVAR in place of open aorta surgeries.
Talk to one of our sales representative about the full report by providing your details in the link below:
Drivers – Endovascular Aneurysm Repair Market
High popularity of FEVAR procedure, emergence of EVAS procedure, high preference for MI aneurysm repair and growth in mergers and acquisitions by key market players have fuelled the market growth in recent years. Commercialization of innovative grafts such as fenestrated aortic stent grafts has further broadened the treatment options for aortic aneurysm, thereby increasing the market for aortic stent grafts. As a result, this is set to drive the market growth in the coming years.
The evolution of aortic endovascular therapies over the past decade has been on a large scale in the imaging field. Accurate preprocedural imaging, improvements in intraoperative technology, and new endograft technologies for increased deployment accuracy and stent graft placement have established endovascular aneurysm repair (EVAR), versus open surgical repair, as the ideal procedure. Key players like Medtronic Plc are using advantage and many of their patents and products are in pipeline, for the upcoming years. As such, the market is poised to see significant growth during the forecast period 2020-2025.
Challenges – Endovascular Aneurysm Repair Market
Technical expertise in both endovascular and open treatment is necessary for a comprehensive aortic aneurysm surgery practice. In addition, the minimally invasive nature of EVAR comes at the cost of radiation and iodinated-contrast exposure. Efforts to reduce radiation exposure to both the patient and provider are centered on public interests. Government policies to reduce costs sometimes cause lesser profit margin and hence, demotivation for key market players. Thus, it is anticipated to hamper the market growth during the forecast period 2020-2025.
Endovascular Aneurysm Repair Industry Outlook
Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Endovascular Aneurysm Repair Market. In 2019, Endovascular Aneurysm Repair Market share is consolidated by the top players present in the market. Endovascular Aneurysm Repair Market top 10 companies are Abbott Laboratory, C R Bard, Inc, Cardinal Health Inc, Cook Medical Inc, Endologix Inc, Lombard Medical, Inc, Medtronic Plc, Merck Co, Inc, Terumo Corporation and W L Gore Associates, Inc among others.
Vascular Graft Market
Hernia Mesh Devices Market
About IndustryARC : IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to email@example.com to discuss more about our consulting services.